Can you provide the average price target for EURONEXT NV stock?
20 analysts have analysed ENX.PA and the average price target is 152.64 EUR. This implies a price increase of 5.48% is expected in the next year compared to the current price of 144.7.
EPA:ENX • NL0006294274
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EURONEXT NV (ENX.PA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-04-06 | Jefferies | Maintains | Buy -> Buy |
| 2021-08-06 | Credit Suisse | Initiate | |
| 2021-05-24 | UBS | Initiate | Buy |
| 2021-03-03 | Jefferies | Initiate | Buy |
| 2021-02-18 | Deutsche Bank | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.475B 3.94% | 1.627B 10.32% | 1.819B 11.79% | 1.995B 9.69% | 2.105B 5.51% | 2.236B 6.22% | 2.075B -7.20% | 2.128B 2.55% | 2.227B 4.65% | 2.327B 4.49% | |
| EBITDA YoY % growth | 864.666M 6.40% | 1.006B 16.40% | 1.124B 11.69% | 1.233B 9.69% | 1.32B 7.06% | 1.377B 4.32% | 1.344B -2.40% | N/A | N/A | N/A | |
| EBIT YoY % growth | 694.535M 6.45% | 817.712M 17.74% | 924.2M 13.02% | 1.09B 17.94% | 1.181B 8.35% | 1.249B 5.76% | 1.082B -13.37% | N/A | N/A | N/A | |
| Operating Margin | 47.10% | 50.26% | 50.81% | 54.64% | 56.10% | 55.86% | 52.14% | N/A | N/A | N/A | |
| EPS YoY % growth | 5.50 5.97% | 6.57 19.45% | 7.27 10.65% | 7.72 6.14% | 8.41 8.93% | 9.09 8.11% | 9.41 3.55% | N/A | N/A | N/A |
All data in EUR
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.93 7.34% | 2.03 0.33% | 1.91 16.27% | 2.02 11.36% | 2.34 20.99% | 2.35 15.95% | 2.29 19.92% | 2.25 11.84% | 2.48 6.29% | 2.29 -2.43% | 2.44 6.89% | 2.15 -4.57% |
| Revenue Q2Q % growth | 511.77M 11.62% | 508.13M 9.09% | 495.39M 13.08% | 523.46M 12.02% | 564.09M 10.22% | 550.79M 8.40% | 541.79M 9.37% | 557.54M 6.51% | 581.76M 3.13% | 559.54M 1.59% | 548.43M 1.23% | 554.49M -0.55% |
| EBITDA Q2Q % growth | 320.6M 8.97% | 313.56M -46.98% | 311.63M -16.18% | 318.92M -71.63% | 369.82M 15.35% | 352.72M 12.49% | 350.7M 12.54% | 342.63M 7.43% | 381.78M 3.23% | 354.51M 0.51% | 350.47M -0.07% | 324.21M -5.38% |
| EBIT Q2Q % growth | 287.02M 16.72% | 279.13M -43.60% | 276.22M 22.22% | 298.57M -67.69% | 353.39M 23.12% | 346.09M 23.99% | 346.71M 25.52% | 351.41M 17.70% | N/A | N/A | N/A | N/A |
All data in EUR
20 analysts have analysed ENX.PA and the average price target is 152.64 EUR. This implies a price increase of 5.48% is expected in the next year compared to the current price of 144.7.
EURONEXT NV (ENX.PA) will report earnings on 2026-05-19.
The consensus EPS estimate for the next earnings of EURONEXT NV (ENX.PA) is 1.93 EUR and the consensus revenue estimate is 511.77M EUR.
The consensus rating for EURONEXT NV (ENX.PA) is 73 / 100 . This indicates that analysts generally have a positive outlook on the stock.